Latao, Bebina .

HRN: 26-57-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFTRIAXONE 1G (VIAL)
01/21/2025
01/27/2025
IV
2g
OD
UTI
Waiting Final Action 
01/29/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
01/29/2025
02/05/2025
TOPICAL
1%
BID
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: